Omega Therapeutics Inc (OMGA) — Cash Flow-to-Debt Ratio
Omega Therapeutics Inc (OMGA) has a Cash Flow-to-Debt Ratio of -0.10x as of September 2024, meaning its operating cash flow of $-14.02 Million could theoretically repay 0% of its total liabilities ($141.18 Million) in one year. See Omega Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Omega Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2023)
Historical debt coverage capacity for Omega Therapeutics Inc across 5 annual periods. Also explore net asset momentum of Omega Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Omega Therapeutics Inc (2019–2023)
Year-by-year debt coverage analysis for Omega Therapeutics Inc. For market capitalisation and broader financial context, see Omega Therapeutics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.63x | $-91.51 Million | $146.35 Million | ▲ +74.6% |
| 2022 | -2.46x | $-98.52 Million | $40.03 Million | ▼ -39.7% |
| 2021 | -1.76x | $-57.61 Million | $32.70 Million | ▼ -524.9% |
| 2020 | -0.28x | $-26.13 Million | $92.71 Million | ▲ +24.4% |
| 2019 | -0.37x | $-15.68 Million | $42.04 Million | — |